Endometrial carcinoma: The current role of adjuvant radiation

A. J. Fakiris, M. E. Randall

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Endometrial cancer is the most common gynaecological malignancy in the USA, expected to account for over 40,000 new cases and 7,400 deaths in 2008. Risk factors for local-regional recurrence after surgery have been identified in surgical-pathological studies as well as prospective randomised trials. While most women with early stage, low risk disease do well without adjuvant therapy, those in higher risk groups frequently recur both locally and distantly. The use of adjuvant radiation therapy has been controversial since randomised trials have demonstrated improvement in local control, without a clear impact on survival. The magnitude of potential benefit is dependent on combinations of risk factors. In this review, we use the available data to help guide the selection of patients for whom radiotherapy may be beneficial, and provide recommendations regarding treatment volumes and methods of delivery.

Original languageEnglish
Pages (from-to)81-89
Number of pages9
JournalJournal of Obstetrics and Gynaecology
Issue number2
StatePublished - Feb 2009


  • Endometrial adenocarcinoma
  • Radiation therapy
  • Uterine cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Endometrial carcinoma: The current role of adjuvant radiation'. Together they form a unique fingerprint.

Cite this